Research Framework Sample Clauses

Research Framework. Decision support increasingly requires the ability to manage, combine and use information from heterogeneous sources.. Figure 3.1 depicts framework for decision support based on four pillars related to semantic interoperabil- ity, GIS interoperability, query processing and P2P architectures. In the following, the main characteristics and issues of the four pillars is presented. Figure 3.1: Four Pillars Research Famework 3.2.1 Semantic Interoperability, characteristics and is- sues Research on interoperability is shifting from communication level to high operational level where data semantics play an important role. Informa- tion heterogeneity can occur at the syntactic, structural and semantic level. Semantic interoperability is more acute in dynamic and autonomous envi- ronments, due to the lack of relationships among sources. Semantic inter- operability is essentially based on having a common understanding of the meaning of the information exchanged by di erent sources. It's a multi-level problem that can occur in data sources, fromats or models. The main characteristics of semantic interoperability pillar are: Semi-structure data models such as XML are used to model web oriented data and to facilitate interoperability. XML is widely ac- cepted as the de facto standard for data modeling and exchange in web environments. XML (eXtensible Markup Language) is a textual language that provides a structural description (and re- lated semantic) of information. It allows the de nition of schema in XML Schema or grammars to represent the conceptual char- acteristics of information systems. XML is a meta-language from which several variants have been derived for di erent domains in the last few years. Examples of languages derived from XML in- clude GML (Geography Markup Language), Global Positioning System Markup Language (GPSML). XML is foundation syntax for upper layer in semantic and ontology model, such as RDF, OWL. Ontologies are increasingly used in interoperable systems, to cap- ture the meanings and relationships of concepts used in various domains. Xxxxxx [47] de nes an ontology as an explicit speci ca- tion of a conceptualization of the real world entities of an applica- tion domain. An ontology is a vocabulary composed of terms and relationships among them. Several studies have been devoted to ontology representation lan- guages: they range from informal natural languages to formal languages based on predicate logic or graph concepts. Among the formal l...
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Research Framework. The general research framework, which will be the base for the outline of the research plans in WP5 is illustrated in Figure 9. To take a closer look at the fruit and diet balance situation in all of the six participating WBC countries an insight in the (interaction between) market actors and consumers is needed. Without consumers there will be no consumption, but without the market there’s nothing to consume at all. The different parts of the model are presented visually below. FP7 KBBE 2007 1 GA 212579 FOCUS-BALKANS DL 1.2 Description of State of the art of the theoretical approaches methods market and consumer studies already available for the Balkans.doc The characteristics in e.g. trends, innovation and communication, of the market are based on indicators that describes performance that influence consumers fruit choice. Concerning the market, we look briefly at developments in the fruit sector to come to a overview of the fruit sector and give an insight in the Balkan producing fruit industry and their market expectations. In order to remain licenced to operate (to survive) market actors have to anticipate and act upon current situation. They carefully watch developments within, have knowledge, and we are going to discuss these with relevant experts to reveal the needed overview. Topics for discussion during the interviews are current and future situation, elements of a SWOT and the marketing-mix and their interaction with consumers. Examples of questions: “ Is the fruit sector competitive in terms of new products?” , “Do the market actors anticipate new trend's?”, or “How do they act upon current competitive situations?”, As can be seen from Figure 9 a lot of aspects are relevant regarding consumer food consumption choices. The total palette holds more topics than can be subject of research. We therefore focus on the exploration of motivations and barriers as the background of consumption and purchase of fruit, and the position of fruit in a well-balanced diet and intend identify the role and barriers to fruit consumption and consumer characteristics in relation to nutrition. To this end, an (in-dept) insight in the perception of consumers is needed. The perception of consumers, is based on a stimulus which is differently perceived according to the consumer characteristics, time and situation. Examples of questions: “Which kind of fruit do they prefer in which situation” , “Do the consumer think he has a healthy life stile” or “What benefits does the...
Sample 1
Research Framework. In my thesis I am studying why European nations have created new sub-regional MDCs and have re-energized old ones in the last couple of years, instead of using the existing NATO and EU institutional frameworks for military collaboration. To conduct my research I apply the multiple-case study research method elaborated by Xxxxxx X. Xxx, who distances this approach from the classical survey based concept of case studies and adapts the logic of the experimental method. Based on this approach, I investigate three cases – the British-French ‘Lancaster House Treaties’, the Nordic Defence Co-operation, and the Central European Defence Co-operation – by testing three rival explanations using the method of pattern matching, which means that I generate predicted patterns regarding the studied phenomenon and compare them to empirically based patterns. The three rival explanations which I will compare regarding the creation of new sub-regional MDCs are 1) the lack of progress on pan- European/Transatlantic defence cooperation 2) the impacts of the financial crisis, 3) different emerging shared threat perceptions of European states.
Sample 1
Research Framework. This section aims at presenting and discussing the Research Framework (RF) by introducing different dimensions of work and organization influenced by XxXXX. We can represent such influence as a multi-dimensional space, characterised at least according to: D1: object (unit of analysis) D2: phase in the life-cycle of the object D3: geographical location D4: digital technology adopted and used by the object D5: strength of organizational ties D6: size of the object D7: industrial sector To clarify how this RF can be applied we provide an example for each level of analysis that the framework is taking into consideration: L1 – an individual; L2 – an organization. D1: object (unit of analysis): an individual (L1) • D1.1 competence profile
Sample 1
Research Framework. For conducting a research at Vestbase we have followed the framework shown in figure 1- 1. We have conducted our research in five steps. First we have identified the information requirements for quay allocation. In this phase we have conducted unstructured detailed interview with the management. We have also observed the process, and studied documents. As a result we developed business process model in Unified modeling language (UML). To validate our business process models design and information requirements findings, we showed these models and findings to the management. After management suggestions and correction we were able to develop information requirements for quay allocation process. In second phase, we have identified that information visibility gap. For this purpose we developed information index table as shown in table 5-3. In this phase we have tried to identify what information is available, how much it is available, and who own this information.
Sample 1

Related to Research Framework

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Technology Research Analyst Job# 1810 General Characteristics

  • Research Support (a) Having regard to the resources reasonably available for such purposes, the Operator will cooperate with AHS to provide such participation by its Staff as may be reasonable in relation to the carrying out of research within the Province. (b) The Operator agrees to promptly notify AHS in the event that it undertakes or agrees to participate in any form of clinical trial, research project, instrument use, or similar activity which in any way relates to the Services provided under this Agreement. The Operator shall, upon request, provide AHS with written evidence of Client disclosure and consent to research.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Development Program RWJPRI shall be [**] and have [**] in consultation with the JDAC, to select LICENSED COMPOUNDS which shall then be designated PRODUCTS for further DEVELOPMENT by RWJPRI and marketing by ORTHO and its AFFILIATES. RWJPRI shall provide KOSAN with written notice of its decision to select a LICENSED COMPOUND for DEVELOPMENT. Once a PRODUCT has been selected for further DEVELOPMENT, RWJPRI, with the advice of the JDAC, shall have the [**] right to develop the PRODUCT through STAGES O, I, II and III and shall have the [**] right to prepare and file, and shall be the owner of, all applications for MARKETING AUTHORIZATION throughout the world. During such DEVELOPMENT efforts, KOSAN will assist RWJPRI as may be mutually agreed, at RWJPRI's expense, in chemical development, formulation development, production of labeled material and production of sufficient quantities of material for STAGE O and initial STAGE I studies. RWJPRI shall exercise diligent efforts, commensurate with the efforts it would normally exercise for products with similar potential sales volume and consistent with its overall business strategy, in developing such PRODUCT in accordance with the DEVELOPMENT PLAN established by RWJPRI. In the course of such efforts RWJPRI shall, either directly or through an AFFILIATE or SUBLICENSEE to which the license shall have been extended, take appropriate steps including the following: (i) in consultation with the JDAC, select certain LICENSED COMPOUNDS for STAGE O DEVELOPMENT; and (ii) establish and maintain a program reasonably designed, funded and resourced to obtain information adequate to enable the preparation and filing with an appropriate and properly empowered national regulatory authority all necessary documentation, data and [**] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. other evidence required for IND non-rejection to commence and conduct human clinical trials of such PRODUCT. (iii) proceed following IND non-rejection to commence PHASE I, II, and III clinical trials, associated studies and such other work which RWJPRI reasonably deems to be required for subsequent inclusion in filings for MARKETING AUTHORIZATION; (iv) after such submissions are filed prosecute such submissions and file all reasonably necessary, reports and respond to all reasonable requests from the pertinent regulatory, authorities for information, data, samples, tests and the like.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Research Primary Investigator as part of a multi-site study (25 points) • Co-Investigator as part of a multi-site study (20 points) • Primary Investigator of a facility/unit based research study (15 points) • Co-Investigator of a facility/unit based research study (10 points) • Develops a unit specific research proposal (5 points) • Conducts a literature review as part of a research study (5 points)

  • Research Use Reporting To assure adherence to NIH GDS Policy, the PI agrees to provide annual Progress Updates as part of the annual Project Renewal or Project Close-out processes, prior to the expiration of the one (1) year data access period. The PI who is seeking Renewal or Close-out of a project agree to complete the appropriate online forms and provide specific information such as how the data have been used, including publications or presentations that resulted from the use of the requested dataset(s), a summary of any plans for future research use (if the PI is seeking renewal), any violations of the terms of access described within this Agreement and the implemented remediation, and information on any downstream intellectual property generated from the data. The PI also may include general comments regarding suggestions for improving the data access process in general. Information provided in the progress updates helps NIH evaluate program activities and may be considered by the NIH GDS governance committees as part of NIH’s effort to provide ongoing stewardship of data sharing activities subject to the NIH GDS Policy.

  • Research Program The term “Research Program” shall mean the research program to be undertaken by TSRI under the direction and control of the Principal Investigator as expressly set forth on Exhibit A hereto.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!